Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes
Crossref DOI link: https://doi.org/10.1245/s10434-016-5584-6
Published Online: 2016-09-23
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fracol, Megan
Datta, Jashodeep
Lowenfeld, Lea
Xu, Shuwen
Zhang, Paul J.
Fisher, Carla S.
Czerniecki, Brian J.
License valid from 2016-09-23